GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Easywell Biomedicals Inc (ROCO:1799) » Definitions » Debt-to-Revenue

Easywell Biomedicals (ROCO:1799) Debt-to-Revenue : 1.42 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Easywell Biomedicals Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Easywell Biomedicals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$68.0 Mil. Easywell Biomedicals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$349.7 Mil. Easywell Biomedicals's annualized Revenue for the quarter that ended in Mar. 2024 was NT$293.7 Mil. Easywell Biomedicals's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 1.42.


Easywell Biomedicals Debt-to-Revenue Historical Data

The historical data trend for Easywell Biomedicals's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easywell Biomedicals Debt-to-Revenue Chart

Easywell Biomedicals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 1.18 1.65 1.96 1.42

Easywell Biomedicals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.35 1.43 1.50 1.00 1.42

Competitive Comparison of Easywell Biomedicals's Debt-to-Revenue

For the Medical Devices subindustry, Easywell Biomedicals's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Easywell Biomedicals's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Easywell Biomedicals's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Easywell Biomedicals's Debt-to-Revenue falls into.



Easywell Biomedicals Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Easywell Biomedicals's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(55.895 + 330.448) / 271.628
=1.42

Easywell Biomedicals's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(68.002 + 349.67) / 293.672
=1.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Easywell Biomedicals Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Easywell Biomedicals's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Easywell Biomedicals (ROCO:1799) Business Description

Traded in Other Exchanges
N/A
Address
No.10, Yanfa 2nd Rd, Hsinchu Science Park, 1st floor, Hsinchu, TWN, 30076
Easywell Biomedicals Inc is engaged in the design, manufacture, and sales of thermometers for measuring body temperature and other medical instruments such as digital clinical thermometers, infrared ear thermometers, probe covers, and blood/urine/total cholesterol metabolites monitoring systems, among others. It has a Drug development segment and Other segments.

Easywell Biomedicals (ROCO:1799) Headlines

No Headlines